Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.72 GBX | -2.62% | -3.63% | +0.81% |
Apr. 22 | Plant Health Care hails Harpinab approval in Belgium | AN |
Apr. 22 | Plant Health Care's Fertilizer Receives Belgian Approval | MT |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 16.53 | 22 | 46 | 41.42 | 36.6 | 15.95 | 15.95 |
Enterprise Value (EV) 1 | 12.24 | 20.04 | 42.08 | 33.4 | 31.22 | 11.15 | 10.85 |
P/E ratio | - | - | -18.3 x | -6.8 x | -3.98 x | - | - |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | 2.03 x | 3.42 x | 6.96 x | 4.91 x | 3.11 x | 1.33 x | 0.96 x |
EV / Revenue | 1.51 x | 3.11 x | 6.36 x | 3.96 x | 2.65 x | 0.93 x | 0.65 x |
EV / EBITDA | -1.64 x | -5.38 x | -12.9 x | -7.23 x | -8.47 x | -3.98 x | -54.2 x |
EV / FCF | -1.92 x | - | - | - | - | -3.18 x | 12.1 x |
FCF Yield | -52.2% | - | - | - | - | -31.4% | 8.3% |
Price to Book | - | - | - | - | - | 1.41 x | 1.37 x |
Nbr of stocks (in thousands) | 172,823 | 207,387 | 251,990 | 304,662 | 306,937 | 341,533 | 341,533 |
Reference price 2 | 0.0956 | 0.1061 | 0.1825 | 0.1360 | 0.1193 | 0.0467 | 0.0467 |
Announcement Date | 4/10/19 | 4/24/20 | 4/23/21 | 5/12/22 | 5/2/23 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales 1 | 8.128 | 6.436 | 6.611 | 8.432 | 11.77 | 12 | 16.6 |
EBITDA 1 | -7.445 | -3.726 | -3.267 | -4.618 | -3.686 | -2.8 | -0.2 |
EBIT 1 | -8.033 | -4.127 | -3.568 | -6.381 | -9.238 | -2.1 | 0.5 |
Operating Margin | -98.83% | -64.12% | -53.97% | -75.68% | -78.51% | -17.5% | 3.01% |
Earnings before Tax (EBT) 1 | - | - | -3.304 | -6.415 | -9.447 | -2.7 | -0.1 |
Net income 1 | - | - | -3.224 | -6.304 | -9.483 | -2.8 | -0.1 |
Net margin | - | - | -48.77% | -74.76% | -80.59% | -23.33% | -0.6% |
EPS 2 | - | - | -0.0100 | -0.0200 | -0.0300 | - | - |
Free Cash Flow 1 | -6.387 | - | - | - | - | -3.5 | 0.9 |
FCF margin | -78.58% | - | - | - | - | -29.17% | 5.42% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 4/10/19 | 4/24/20 | 4/23/21 | 5/12/22 | 5/2/23 | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - |
Net Cash position 1 | 4.28 | 1.96 | 3.92 | 8.02 | 5.39 | 4.8 | 5.1 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow 1 | -6.39 | - | - | - | - | -3.5 | 0.9 |
ROE (net income / shareholders' equity) | - | - | - | - | - | -18.3% | 5.4% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | - | - | - | - | 0.0300 | 0.0300 |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex 1 | 0.12 | 0.13 | 0.02 | 0.38 | 0.13 | - | - |
Capex / Sales | 1.41% | 2.05% | 0.23% | 4.53% | 1.13% | - | - |
Announcement Date | 4/10/19 | 4/24/20 | 4/23/21 | 5/12/22 | 5/2/23 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.81% | 15.95M | |
+1.17% | 15.17B | |
-14.18% | 15.06B | |
+6.58% | 12.61B | |
-13.42% | 9.92B | |
-12.24% | 7.34B | |
-6.06% | 6.42B | |
-3.50% | 4.25B | |
-27.17% | 2.43B | |
+2.63% | 2.07B |
- Stock Market
- Equities
- PHC Stock
- Financials Plant Health Care plc